Results for

Eating Disorder Prevention in Schools Act of 2020 This bill requires local educational agencies (LEAs) participating in the school lunch or breakfast programs to include goals for reducing disordered eating in children of all sizes in their local school wellness policies. Such LEAs must also include registered dietitians and licensed mental health professionals in the development, implementation, and periodic review of such policies. The bill also requires the Department of Agriculture to provide information and technical assistance to LEAs, school food authorities, school health professionals, and state educational agencies for use in establishing healthy school environments. Such technical assistance must promote eating disorder prevention and encourage screening for such disorders.

Functional Gastrointestinal and Motility Disorders Research Enhancement Act of2019 This bill allows the National Institutes of Health to expand, intensify, and coordinate its activities with respect to functional gastrointestinal and motility disorders (FGIMDs), including by * expanding basic and clinical research into FGIMDs by implementing the research recommendations of the National Commission on Digestive Diseases, * providing support for the establishment of centers of excellence on FGIMDs, * supporting innovative approaches to educating health care providers and patients regarding strategies that improve patient-provider relationships and care, * directing the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to provide the necessary funding for the continued expansion and advancement of the FGIMDs research portfolio, and * directing NIDDK and the Eunice Kennedy Shriver National Institute of Child Health and Human Development to expand research into FGIMDs that impact children. The Department of Health and Human Services may engage in public awareness and education activities to increase understanding and recognition of FGIMDs.

Aidan's Law This bill authorizes newborn screenings for adrenoleukodystrophy (also known as ALD), which is a hereditary condition that damages the insulating membrane of nerve cells in the brain. The bill authorizes hospitals, child care centers, clinics, and similar institutions to test newborns for ALD in accordance with state protocols; such protocols must be approved by the Discretionary Advisory Committee on Heritable Disorders in Newborns and Children. The bill also reauthorizes for FY2020-FY2023 the heritable disorders screening program for newborns and children that is administered by the Health Resources and Services Administration.

This resolution recognizes addiction as a treatable, chronic medical disease and supports evidence-based treatment for substance use disorder and efforts to prevent and destigmatize addiction.

This resolution expresses the sense of the House of Representatives that investments in mental health care and substance use disorder care are necessary to address the high prevalence of those suffering from behavioral health conditions. It also recognizes the need for health care reform to integrate mental health care and substance use disorder treatment in the health care system.

Family Support Services for Addiction Act of 2020 This bill directs the Substance Abuse and Mental Health Services Administration to award grants to certain nonprofits to develop or expand services for individuals with substance use disorders and their families. Activities may include (1) developing education, resources, and trainings on issues related to substance use disorders and family support; (2) reducing stigma; and (3) educating health care providers about substance use disorders in families.

Family Support Services for Addiction Act of 2020 This bill directs the Substance Abuse and Mental Health Services Administration to award grants to certain nonprofits to develop or expand services for individuals with substance use disorders and their families. Activities may include (1) developing education, resources, and trainings on issues related to substance use disorders and family support; (2) reducing stigma; and (3) educating health care providers about substance use disorders in families.

VA Serious Mental Illness Act This bill requires the Department of Veterans Affairs (VA) to complete the development of a clinical practice guideline or guidelines for the treatment of serious mental illness. Under the bill, such guidelines must address the treatment of schizophrenia, schizoaffective disorder, and persistent mood disorder (including bipolar disorder I and II). The VA must carry out an explicit plan to implement and disseminate the clinical practice guideline or guidelines that are developed. The VA must establish the Serious Mental Illness Work Group with the Department of Defense and the Department of Health and Human Services to develop such clinical practice guideline or guidelines. Finally, the VA must complete an assessment of the2016 Clinical Practice Guidelines for the Management of Major Depressive Disordersto determine if an update is necessary.

Improving Mental Health Care for Veterans Act of 2020 This bill requires the Department of Veterans Affairs (VA) to complete the development of a clinical practice guideline or guidelines for the treatment of serious mental illness. Under the bill, such guidelines must address the treatment of schizophrenia, schizoaffective disorder, and persistent mood disorder (including bipolar disorder I and II). The VA must establish the Serious Mental Illness Work Group with the Department of Defense and the Department of Health and Human Services to develop such clinical practice guideline or guidelines. Finally, the VA must complete an assessment of the2016 Clinical Practice Guidelines for the Management of Major Depressive Disordersto determine if an update is necessary.

Emergency Support for Substance Use Disorders Act This bill requires the Substance Abuse and Mental Health Services Administration to award grants to states, other jurisdictions, and community-based entities for harm reduction activities to address drug misuse during the COVID-19 (i.e., coronavirus disease 2019) pandemic.

This resolution (1) designates February 28, 2019, as Rare Disease Day; (2) recognizes the importance of improving awareness and encouraging accurate and early diagnosis of rare diseases and disorders; and (3) expresses support for a national and global commitment to developing new treatments, diagnostics, and cures for rare diseases and disorders.

This resolution supports the designation of Pain Awareness Month to bring attention to migraine and headache disorders and their disproportionate impact on women.

This resolution expresses support for (1) the designation of Rare Disease Day; and (2) a national and global commitment to developing new treatments, diagnostics, and cures for rare diseases and disorders.

This resolution expresses support for (1)the designation of Rare Disease Day; and (2)a national and global commitment to developing new treatments, diagnostics, and cures for rare diseases and disorders.

Setting Treatment Options and Practices for Veteran Suicide and Substance Abuse Act or the STOP Veteran Suicide and Substance Abuse Act This bill requires the Department of Veterans Affairs (VA) to complete the development of clinical practice guidelines for the treatment of post-traumatic stress disorder (PTSD), military sexual trauma, and traumatic brain injury that is occurring simultaneously with substance use disorder or chronic pain. The VA, the Department of Defense (DOD), and the Department of Health and Human Services must create a Trauma and Comorbid Substance Use Disorder or Chronic Pain Work Group to develop such clinical practice guidelines in consultation with other work groups, including the Substance Use Work Group. The bill also requires the VA and DOD (through the Assessment and Management of Patients at Risk for Suicide Work Group) to issue an update to the VA/DOD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide that considers gender- and age-specific factors.

This bill extends the tax exclusion of damages on account of injuries or sickness to include post-traumatic stress disorder.

Warrior Wellness Act This bill directs the Department of Defense (DOD) to report to congressional committees on its shortage of mental health providers and include a strategy to better recruit and retain mental health providers. DOD must report on the practices for prescribing medication during a specified period that were inconsistent with the post-traumatic stress disorder medication guidelines developed by DOD and the Veterans Health Administration (VHA). The Departments of the Army, Navy, and Air Force must each establish a monitoring program to (1) periodically review the medication prescribing practices of providers and report the results to DOD and the VHA, and (2) establish procedures to address prescribing practices that are inconsistent with post-traumatic stress disorder medication guidelines developed by the departments.

This resolution supports designating National Dystonia Awareness Month to raise public awareness and understanding of the condition and recognizes the need for additional research to find a cure. (Dystonia is a neurological disorder that is characterized by repetitive, involuntary muscle contractions.)

This resolution expresses the support of the House of Representatives for recognized standards of education, training, and skills to deliver substance use disorder counseling and recognizes the addiction professionals who provide these services.